X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON LTD vs ABBOTT INDIA - Comparison Results

BIOCON LTD    Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON LTD ABBOTT INDIA BIOCON LTD/
ABBOTT INDIA
 
P/E (TTM) x 100.2 35.1 285.2% View Chart
P/BV x 8.2 10.2 80.5% View Chart
Dividend Yield % 0.2 0.6 25.2%  

Financials

 BIOCON LTD   ABBOTT INDIA
EQUITY SHARE DATA
    BIOCON LTD
Mar-17
ABBOTT INDIA
Mar-17
BIOCON LTD/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs1,1625,190 22.4%   
Low Rs4834,351 11.1%   
Sales per share (Unadj.) Rs194.61,382.9 14.1%  
Earnings per share (Unadj.) Rs34.4130.2 26.4%  
Cash flow per share (Unadj.) Rs48.3137.9 35.0%  
Dividends per share (Unadj.) Rs1.0040.00 2.5%  
Dividend yield (eoy) %0.10.8 14.5%  
Book value per share (Unadj.) Rs241.9652.7 37.1%  
Shares outstanding (eoy) m200.0021.25 941.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.23.4 122.5%   
Avg P/E ratio x23.936.6 65.2%  
P/CF ratio (eoy) x17.034.6 49.3%  
Price / Book Value ratio x3.47.3 46.5%  
Dividend payout %2.930.7 9.5%   
Avg Mkt Cap Rs m164,440101,373 162.2%   
No. of employees `0009.23.1 299.5%   
Total wages/salary Rs m7,4703,453 216.4%   
Avg. sales/employee Rs Th4,213.99,531.9 44.2%   
Avg. wages/employee Rs Th809.01,119.9 72.2%   
Avg. net profit/employee Rs Th745.2897.3 83.0%   
INCOME DATA
Net Sales Rs m38,91129,387 132.4%  
Other income Rs m1,571576 272.6%   
Total revenues Rs m40,48229,963 135.1%   
Gross profit Rs m9,7953,973 246.5%  
Depreciation Rs m2,772164 1,687.2%   
Interest Rs m26020 1,274.5%   
Profit before tax Rs m8,3344,365 190.9%   
Minority Interest Rs m1630-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6161,598 101.1%   
Profit after tax Rs m6,8812,767 248.7%  
Gross profit margin %25.213.5 186.2%  
Effective tax rate %19.436.6 53.0%   
Net profit margin %17.79.4 187.8%  
BALANCE SHEET DATA
Current assets Rs m40,47718,906 214.1%   
Current liabilities Rs m16,7836,297 266.5%   
Net working cap to sales %60.942.9 141.9%  
Current ratio x2.43.0 80.3%  
Inventory Days Days6062 95.8%  
Debtors Days Days8322 382.9%  
Net fixed assets Rs m45,0731,159 3,889.7%   
Share capital Rs m1,000213 470.6%   
"Free" reserves Rs m47,37713,657 346.9%   
Net worth Rs m48,37713,869 348.8%   
Long term debt Rs m21,0820-   
Total assets Rs m93,94220,638 455.2%  
Interest coverage x33.1215.0 15.4%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.41.4 29.1%   
Return on assets %7.613.5 56.3%  
Return on equity %14.219.9 71.3%  
Return on capital %12.631.6 39.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m12,9880-   
Fx outflow Rs m7,8990-   
Net fx Rs m5,0890-   
CASH FLOW
From Operations Rs m6,4003,072 208.3%  
From Investments Rs m-4,985-1,554 320.8%  
From Financial Activity Rs m-1,775-898 197.7%  
Net Cashflow Rs m-473621 -76.2%  

Share Holding

Indian Promoters % 40.4 0.0 -  
Foreign collaborators % 20.6 75.0 27.5%  
Indian inst/Mut Fund % 8.4 7.9 106.3%  
FIIs % 10.7 0.1 10,700.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 17.1 116.4%  
Shareholders   109,995 18,270 602.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON LTD With:   SANOFI INDIA  TORRENT PHARMA  FRESENIUS KABI ONCO.  CIPLA  ASTRAZENECA PHARMA  

Compare BIOCON LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Up; ONGC & Tata Steel Top Gainers(Closing)

Indian share markets ended the day on a strong note. At the closing bell, the BSE Sensex finished higher by 262 points. While, the NSE Nifty finished up by 91 points.

Related Views on News

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Beware the 5th year of the Modi Regime(The Honest Truth)

May 22, 2018

2017 was a great year for the market. You were rewarded for taking excessive risk. But Ajit Dayal believes 2018 will be different. You will be rewarded for doing the opposite. Read on to know more...

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON LTD SHARE PRICE


May 25, 2018 (Close)

TRACK BIOCON LTD

  • Track your investment in BIOCON LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

BIOCON LTD - PANACEA BIOTECH COMPARISON

COMPARE BIOCON LTD WITH

MARKET STATS